KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Long-Term Deferred Tax (2021 - 2024)

Moderna (MRNA) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $81.0 million as the latest value for Q3 2024.

  • Quarterly Long-Term Deferred Tax changed N/A to $81.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Sep 2024, changed N/A year-over-year, with the annual reading at $81.0 million for FY2023, 91.75% down from the prior year.
  • Long-Term Deferred Tax for Q3 2024 was $81.0 million at Moderna, roughly flat from $81.0 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $1.5 billion in Q2 2023, with the low at $50.0 million in Q1 2021.
  • Average Long-Term Deferred Tax over 4 years is $485.5 million, with a median of $203.5 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax surged 1089.39% in 2022, then tumbled 94.53% in 2024.
  • Over 4 years, Long-Term Deferred Tax stood at $326.0 million in 2021, then soared by 201.23% to $982.0 million in 2022, then tumbled by 91.75% to $81.0 million in 2023, then changed by 0.0% to $81.0 million in 2024.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $81.0 million, $81.0 million, and $81.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.